Weigh Loss Injections

Weight Loss Injections in the UK: Semaglutide, Tirzepatide, and Retatrutide

Semaglutide for Weight Loss and Diabetes
Semaglutide (Ozempic®/Wegovy®) helps with weight loss (up to 15%) and blood sugar control. It’s FDA-approved and used in UK research, with side effects like nausea and constipation. Available for research purposes only in the UK, not for actual medical use.

Tirzepatide: Dual-Hormone Injection
Tirzepatide (Mounjaro®/Zepbound™) targets GLP-1 and GIP receptors, offering up to 22% weight loss. It’s FDA-approved for diabetes and used in UK research. Side effects can include nausea and vomiting. Available for research purposes only in the UK, not for actual medical use.

Retatrutide: Triple-Hormone Injection
Retatrutide, in clinical trials, shows potential for 24%+ weight loss by targeting GLP-1, GIP, and glucagon receptors. Available only for research in the UK, with GI discomfort as a side effect. Available for research purposes only in the UK, not for actual medical use.

Which Injection Is Right for You?
Semaglutide and tirzepatide are FDA-approved for weight loss and diabetes, while retatrutide is still being studied. All of these are for research purposes only in the UK, not for actual medical use. Always consult a healthcare professional before using these treatments.